1-3 of 3
Yan Cheng
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Critical Role for Cap-Independent c-MYC Translation in Progression of Multiple Myeloma

Yijiang Shi, Fumou Sun, Yan Cheng, Brent Holmes, Binod Dhakal, Joseph F. Gera, Siegfried Janz, Alan Lichtenstein
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (4): 502–510.
https://doi.org/10.1158/1535-7163.MCT-21-0016
Published: 01 April 2022
View article titled, Critical Role for Cap-Independent c-MYC Translation in Progression of Multiple Myeloma
Open the PDF for Critical Role for Cap-Independent c-MYC Translation in Progression of Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

XPO1 (CRM1) Inhibition Represses STAT3 Activation to Drive a Survivin-Dependent Oncogenic Switch in Triple-Negative Breast Cancer

Yan Cheng, Michael P. Holloway, Kevin Nguyen, Dilara McCauley, Yosef Landesman, Michael G. Kauffman, Sharon Shacham, Rachel A. Altura
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2014) 13 (3): 675–686.
https://doi.org/10.1158/1535-7163.MCT-13-0416
Published: 09 March 2014
View article titled, XPO1 (CRM1) Inhibition Represses STAT3 Activation to Drive a Survivin-Dependent Oncogenic Switch in Triple-Negative Breast Cancer
Open the PDF for XPO1 (CRM1) Inhibition Represses STAT3 Activation to Drive a Survivin-Dependent Oncogenic Switch in Triple-Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

MK-2206, a Novel Allosteric Inhibitor of Akt, Synergizes with Gefitinib against Malignant Glioma via Modulating Both Autophagy and Apoptosis

Yan Cheng, Yi Zhang, Li Zhang, Xingcong Ren, Kathryn J. Huber-Keener, Xiaoyuan Liu, Lei Zhou, Jason Liao, Heike Keihack, Li Yan, Eric Rubin, Jin-Ming Yang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (1): 154–164.
https://doi.org/10.1158/1535-7163.MCT-11-0606
Published: 09 January 2012
View article titled, MK-2206, a Novel Allosteric Inhibitor of Akt, Synergizes with Gefitinib against Malignant Glioma via Modulating Both Autophagy and Apoptosis
Open the PDF for MK-2206, a Novel Allosteric Inhibitor of Akt, Synergizes with Gefitinib against Malignant Glioma via Modulating Both Autophagy and Apoptosis in another window
Includes: Supplementary data